India's GlaxoSmithKline Pharma hits near two-year high
** Shares of GlaxoSmithKline Pharmaceuticals GLAX.NS rise
as much as 6.2% to 1,675 rupees, highest since Jan. 24, 2022
** Reuters could not immediately ascertain the reason for
the stock movement
** Stock has risen 13.7% since reporting Q2 profit climb on
Nov. 9
** Over 553,000 shares change hands as of 3:26 p.m. IST, 5X
the 30-day moving average
** Mean rating of five analysts is "hold"; median PT is
1,515 rupees - LSEG data
** Stock up 25% YTD
(Reporting by Varun Vyas in Bengaluru)
((varunvyas.hebbalalu@thomsonreuters.com))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees